On Monday, Qunar Cayman Islands Ltd (NASDAQ:QUNR)’s shares inclined 4.35% to $46.01.
Qunar Cayman Islands Ltd (QUNR) declared the commencement of a registered public offering of its American Depositary Shares (the “ADSs”), each representing three Class B ordinary shares, par value US$0.001 per share (the “Ordinary Shares”), by the Company.
The Company is offering an aggregate of 8,000,000 ADSs, representing 24,000,000 Ordinary Shares, subject to market conditions. The Company intends to grant to the underwriters a 30-day option to purchase up to an aggregate of 1,200,000 additional ADSs. The Company intends to use a majority of the net proceeds for general corporate purposes, counting the acquisition of new users. The Company also may use a portion of the net proceeds to acquire complementary businesses, products, services or technologies. However, the Company has not yet reached any agreements or commitments for any specific acquisitions at this time.
Goldman Sachs (Asia) L.L.C. is acting as book-running manager for the offering and BofA Merrill Lynch is acting as co-manager.
Qunar Cayman Islands Limited operates an online travel commerce platform in the Peoples Republic of China. The company through its platform provides a range of travel products comprising flight tickets, hotels, vacation packages, and attraction tickets, in addition to display advertising, train tickets, car services, smart lodging, and other services.
Sabre Corp (NASDAQ:SABR)’s shares gained 1.46% to $26.47.
Sabre Corp (SABR) awarded Evature and RentalsCombined.net $10,000 in prize money in recognition of being named the best travel apps as part of the third-annual Sabre Appy competition held recently during the 2015 Travel Technology Exchange (TTX) in Dallas.
The Sabre Appy awards are an annual developers’ competition that recognizes the best ideas for new apps to assist Sabre travel agents address challenges and opportunities in their businesses. For the first time, competing apps were divided into two categories – Best Sabre Red App and Best Online B2B Travel App. In addition, a new prize debuted this year for the People’s Choice award, allowing TTX attendees to vote for the app they liked best.
Sabre Corporation provides technology solutions to the travel and tourism industry worldwide. It operates in two segments: Travel Network, and Airline and Hospitality Solutions. The Travel Network segment operates a business-to-business travel marketplace that offers travel content, such as inventory, prices, and availability from a range of travel suppliers, counting airlines, hotels, car rental brands, rail carriers, cruise lines, and tour operators, with a network of travel buyers comprising online and offline travel agencies, travel administration companies, and corporate travel departments.
At the end of Monday’s trade, Clovis Oncology Inc (NASDAQ:CLVS)‘s shares dipped -5.88% to $87.00.
Clovis Oncology Inc (CLVS) declared updated findings from its Phase 2 clinical study of rociletinib (CO-1686), the Company’s novel, oral, targeted covalent (irreversible) mutant-selective inhibitor of the epidermal growth factor receptor (EGFR) for the treatment of non-small cell lung cancer (NSCLC) in patients with initial activating EGFR mutations, in addition to the dominant resistance mutation T790M. These data from the TIGER-X trial are being presented recently in an oral presentation (Abstract #8001) at the 2015 American Society of Clinical Oncology (ASCO) annual meeting in Chicago.
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. It is developing three product candidates which comprise Rociletinib, an oral epidermal growth factor receptor and mutant-selective covalent inhibitor that is in advanced clinical development for the treatment of non-small cell lung cancer; Rucaparib, an oral inhibitor of poly polymerase, which is in advanced clinical development for the treatment of ovarian cancer; and Lucitanib, an oral inhibitor of the tyrosine kinase that is in Phase II development for the treatment of breast and lung cancers.
Canadian Solar Inc. (NASDAQ:CSIQ), ended its Monday’s trading session with -0.95% loss, and closed at $32.35.
Canadian Solar Inc. (CSIQ) declared that it has supplied modules to Turkey’s largest PV project, the Kayseri Organized Industrial Zone PV Plant.
The 7.5 MW (AC) ground-mounted PV plant is located in one of Turkey’s largest industrial zones, the Kayseri Organized Industrial Zone (KOIZ). The plant uses 27,252 pieces of Canadian Solar CS6P-255P modules to reduce the electricity costs for the zone’s 86 million kWh/month energy consumption. On April 18th 2015, the official opening ceremony for Turkey’s largest PV plant was organized in Kayseri with special attendance of the Turkish Minister of Energy and other top-level government officials. The 950 companies producing in the zone now profit from reduced energy costs as the plant generates 10.95 MWh electricity per year, while offsetting CO2 emissions by 7,728 metric tons.
Canadian Solar Inc., together with its auxiliaries, designs, develops, manufactures, and sells solar wafers, cells, and solar power products worldwide. The company operates in two segments, Module and Energy. Its products comprise various solar modules that are used in residential, commercial, and industrial solar power generation systems.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
